How To Build Belonging At A 350,000-Person Company
A conversation between Jacob Aarup-Andersen, CEO of ISS Group, and Mads Holme, managing partner of ReD Associates on making belonging a top priority in a giant people organisation and putting the S in ESG on the leadership agenda.
Taking the climate fight to the oceans and aquatic foods
WorldFish’s interim director general on shifting the climate narrative and using social science to lead organisational change
Deep context: A strategic approach to organisational change
Ed Whiting (Wellcome Trust’s Director of Strategy) speaks to Mads Holme about the big organisational shifts required to deliver on Wellcome’s new strategy, how deeper, more reciprocal partnerships lead to more long-term solutions, and the importance of human understanding in both effecting change and creating equitable cultures.
Being customer oriented never goes out of fashion
A conversation between Britt Meelby Jensen, CEO of AMBU A/S & Mads Holme, Managing Partner at ReD Associates.
Rethinking ‘our work’
Over the past few months, ReD has conducted immersions with a dozen young professionals in Paris, Shanghai, Copenhagen, Stockholm, and NYC across a range of industries to understand their work attitudes, practices, norms, and expectations for employers.
Time to Make Strategic Philanthropy more Human-Focused
Strategic philanthropy does not have to mean a data-driven approach. Instead it embrace its humanist side.
Building a Growth Engine by Balancing Soft and Hard
A conversation with the CEO of Karo on how he made his healthcare company more human-centric.
Getting Fans Right
How getting fans wrong led to chaos in European football, and what we have learned about getting fans right.
‘Out Of The Labs’: The Role for Ethnography in Guiding Clinical Trials
With the new reality of pharmaceutical R&D, companies must deliver impact and value. This paper explores how ethnographic research can fill that role in early stages of pharmaceutical clinical trials.
Avoiding The Most Common Pitfalls When Entering ‘Emerging Markets’
Companies struggle in emerging markets because they underestimate the importance of local culture and social behavior.
Pharma Exec: Develop Drugs For People, Not Just Bodies
Pharma companies are taking steps toward "patient-centric" healthcare by using patient insights to guide drug development and clinical trials.